Patient satisfaction and Quality of life after dienogest treatment versus surgical excision of ovarian endometrioma
Atwa, K., Ibrahim, Z., El Bassuony, E., Taha, O., Elgedawy, A. (2023). Patient satisfaction and Quality of life after dienogest treatment versus surgical excision of ovarian endometrioma. EKB Journal Management System, 27(5), 89-97. doi: 10.21608/egyfs.2023.320851
Khaled A. Atwa; Zakia M. Ibrahim; Eman M. El Bassuony; Omima T. Taha; Asmaa M. Elgedawy. "Patient satisfaction and Quality of life after dienogest treatment versus surgical excision of ovarian endometrioma". EKB Journal Management System, 27, 5, 2023, 89-97. doi: 10.21608/egyfs.2023.320851
Atwa, K., Ibrahim, Z., El Bassuony, E., Taha, O., Elgedawy, A. (2023). 'Patient satisfaction and Quality of life after dienogest treatment versus surgical excision of ovarian endometrioma', EKB Journal Management System, 27(5), pp. 89-97. doi: 10.21608/egyfs.2023.320851
Atwa, K., Ibrahim, Z., El Bassuony, E., Taha, O., Elgedawy, A. Patient satisfaction and Quality of life after dienogest treatment versus surgical excision of ovarian endometrioma. EKB Journal Management System, 2023; 27(5): 89-97. doi: 10.21608/egyfs.2023.320851

Patient satisfaction and Quality of life after dienogest treatment versus surgical excision of ovarian endometrioma

The Egyptian Journal of Fertility of Sterility
Article 12, Volume 27, Issue 5 - Serial Number 11106352, September 2023, Page 89-97  XML PDF (539.54 K)
Document Type: Original Article
DOI: 10.21608/egyfs.2023.320851
View on SCiNiTO View on SCiNiTO
Authors
Khaled A. Atwa1; Zakia M. Ibrahim2; Eman M. El Bassuony3; Omima T. Taha email 4; Asmaa M. Elgedawy5
1Assistant professor of Obstetrics and Gynecology, Department of Obstetrics and Gynecology, Faculty of Medicine, Suez Canal University.
2Professor of Obstetrics and Gynecology, Department of Obstetrics and Gynecology. Faculty of Medicine, Suez Canal University.
3Assistant lecturer of obstetrics and gynecology, Department of Obstetrics and Gynecology. Faculty of Medicine, Suez Canal university.
4Assistant professor of Obstetrics and Gynecology, Department of Obstetrics and Gynecology Faculty of Medicine, Suez Canal University
5Lecturer of Obstetrics and Gynecology, Department of Obstetrics and Gynecology, Faculty of Medicine, Suez Canal University.
Abstract
Background: Endometriosis is a chronic condition affecting females in the reproductive period. Variable medical treatment options have been provided with comparable results to surgery. 
Objective: Comparing dienogest treatment and surgical excision of endometrioma regarding patients' satisfaction and Quality of life.   
Study design: This randomized clinical trial was conducted at a tertiary hospital from Nov 1, 2020, to Jul 31, 2022. We recruited patients according to specific inclusion and exclusion criteria. The study population was randomly allocated into two groups; group one received Dienogest, and group two had laparoscopic cystectomy. Group one patients received medical treatment with Dienogest (2mg/day) starting on the first day of the first menstrual cycle for three months. After three months, patients were subjected to clinical evaluation, including cyst diameter, recurrence after surgical excision, evaluation of patient satisfaction using the endometriosis treatment satisfaction questionnaire (ETSQ), and Quality of life using the SF-36 questionnaire.      
Results: The recurrence rate after excision was 12/60 (20%). There was a significant difference in patient satisfaction after medical treatment rather than surgical excision. This was noted in each item of the satisfaction questionnaire and the total score (p-value <0.05). There was a significant improvement in all aspects of the Quality of life with dienogest therapy rather than surgical treatment (p-value <0.05).
Conclusion: Dienogest greatly improved patients' Quality of life and satisfaction rather than surgical intervention.
Keywords
Keywords: Endometrioma; Dienogest; Surgical excision; Satisfaction; Quality of life
Statistics
Article View: 72
PDF Download: 78